VC
France
New Fund 2024

Kurma Partners

Check Size
€3M – €20M

Investment Focus

Investment Stages

Geographic Focus

Europe

Investment Thesis

European specialist biotech VC (part of Eurazeo group) backing companies from inception through clinical development, with particular strength in university and research institute spinouts in France and Germany.

How to Pitch Kurma Partners

No Stated Policy
Kurma Partners hasn't published an outreach policy. A short, specific cold email is the safest default.

Portfolio Highlights

Amolyt Pharma - rare endocrine disease company; co-led from Series A; acquired by AstraZeneca for $1.05B
SciRhom - autoimmune disease biotech targeting iRhom2 pathway
Memo Therapeutics - natural immunity-inspired antibody therapeutics company

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Kurma Partners?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.